Találati lista | Tudóstér

001-es BibID:	BIBFORM114668
035-os BibID:	(WoS)001095091600001 (Scopus)85175011329
Első szerző:	Szilágyi Tünde (gyógytornász)
Cím:	Efficiency of Printed Patient Information Leaflets Written for Total Knee and Hip Arthroplasty Patients to Reduce Their Fear of Surgery / Szilágyiné Lakatos Tünde, Lukács Balázs, Nagy Attila Csaba, Jenei Zoltán, Veres-Balajti Ilona
Dátum:	2023
ISSN:	2308-3417
Megjegyzések:	Background: Patient education plays a key role in health care. In our study, we created a new information guide for patients waiting for total knee (TKA) or hip (THA) arthroplasty. The goal of our study was to create patient education material that would reduce patients' fear of surgery and improve their postoperative lifestyle. Methods: Patients in the intervention group (n = 44) received newly developed paper-based patient education material before surgery. The surgical fear questionnaire (SFQ) was used to assess fear reduction. A self-designed assessment questionnaire was used to measure the effectiveness of the leaflet among the intervention group patients. Results: The SFQ scores decreased significantly both in patients with TKA (median 37.50 IQR 30.00-40.00 vs. median 20.00 IQR 16.00-24.00) and THA (median 34.50 IQR 28.00-42.00 vs. median 20.00 IQR 16.00-22.00). A control group with TKA (median 37.50 IQR 30.00-40.00 vs. median 64.50 IQR 54.00-82.00) and THA (median 34.50 IQR 28.00-42.00 vs. median 73.00 IQR 56.00-81.00) was also included. An assessment of the content, usability, and clarity of the new leaflet showed that patients rated the new leaflet as almost entirely usable (median score 12.00-10.00). Conclusions: Our results suggest that new printed patient education material may reduce the fear of surgery.
Tárgyszavak:	Orvostudományok Egészségtudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk fear patient education joint endoprosthesis rehabilitation questionnaires
Megjelenés:	Geriatrics. - 8 : 5 (2023), p. 1-12. -
További szerzők:	Lukács Balázs (1978-) (élettanász) Nagy Attila Csaba (1981-) (megelőző orvostan és népegészségtan szakorvos, epidemiológus) Jenei Zoltán (1968-) (belgyógyász) Veres-Balajti Ilona (1965-) (gyógytornász, egészségfejlesztő)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM131830
Első szerző:	Ulambayar, Battamir (orvos)
Cím:	Effect of Anti-Diabetic Medication Use on Sepsis Risk in Type 2 Diabetes Mellitus : a Multivariate Analysis / Battamir Ulambayar, Amr Sayed Ghanem, Attila Csaba Nagy
Dátum:	2025
ISSN:	2308-3417
Megjegyzések:	Abstract Background: Type 2 diabetes mellitus (T2DM) increases sepsis risk due to immune dysfunction and chronic inflammation. Antidiabetic medications, while primarily used for glycemic control, may modulate sepsis susceptibility through immune and inflammatory pathways. This study investigates the association between antidiabetic medication use and sepsis risk in T2DM patients. Methods: A longitudinal cohort study was conducted using clinical registry data from 5009 T2DM patients at the University Hospital, Debrecen, Hungary (2016?2020). Sepsis cases were identified via ICD-10 code A41, and antidiabetic medication use was categorized using ATC codes. Baseline comorbidities and laboratory parameters were extracted. Chi-square and Wilcoxon rank?sum tests assessed associations between sepsis and categorical/numerical variables, respectively. Time-adjusted multivariate logistic regression evaluated predictors of sepsis risk, with odds ratios (ORs) and 95% confidence intervals (CIs) reported. Results: Age, hypertension, ischemic heart disease, nephropathy, elevated blood glucose, C-reactive protein, and creatinine also independently increased sepsis risk. Insulin use was associated with a 2.6-fold increased sepsis risk (OR = 2.6, 95% CI: 2.09?3.34, p < 0.001), while SGLT2 inhibitors (OR = 0.56, 95% CI: 0.34?0.91, p = 0.02) and GLP-1 receptor agonists (OR = 0.39, 95% CI: 0.19?0.79, p = 0.009) were protective. Conclusions: Insulin-treated patients may require closer infection monitoring, while SGLT2 inhibitors and GLP-1 RAs could be prioritized in high-risk individuals. These findings highlight the potential to inform risk stratification and guide personalized antidiabetic therapy to reduce sepsis risk in T2DM.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban folyóiratcikk type 2 diabetes mellitus sepsis insulin sodium-glucose cotransporter-2 (SGLT2) inhibitors glucagon-like peptide-1 (GLP-1) receptor agonists
Megjelenés:	Geriatrics. - 10 : 4 (2025), p. 1-12. -
További szerzők:	Ghanem, Amr Sayed (1991-) (orvos, fogorvos) Nagy Attila Csaba (1981-) (megelőző orvostan és népegészségtan szakorvos, epidemiológus)
Internet cím:	Szerző által megadott URL DOI Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: